期刊文献+

术前血清CA125、CA153和CEA测定在诊断盆腔肿瘤中的意义 被引量:4

原文传递
导出
摘要 目的:探讨手术前血清CA125,CA153以及CEA的测定在诊断盆腔肿瘤中的临床意义。方法:随机选取2007年1月2010年10月在嵊州市中医院妇科就诊的88例盆腔肿瘤患者,运用电化学发光法(ECL)来测量手术前患者的血清CA125、CA153以及CEA的含量。结果:单独的CA125、CA153以及CEA在盆腔肿瘤患者中其敏感性表现都较低,特异性较高,联合CA125与CA153时,其敏感性会有所提高,但是特异性没有明显变化,联合CEA时,结果没有明显变化。结论:CA125是诊断盆腔肿瘤较为理想的指标,结合CA125与CA153会有一定的互补作用。
作者 王丽钗
出处 《中国妇幼保健》 CAS 北大核心 2011年第6期838-840,共3页 Maternal and Child Health Care of China
  • 相关文献

参考文献6

二级参考文献17

  • 1李绍刚.子宫腺肌症病变范围与血清CA125的关系[J].现代实用医学,2008,20(4):301-302. 被引量:4
  • 2刘伯宁,陆丽华.子宫肌腺病临床误诊原因探讨[J].实用妇产科杂志,1993,9(6):315-316. 被引量:70
  • 3李绍刚.子宫腺肌症组织的CA125免疫表达与血清CA125的关系[J].现代实用医学,2006,18(1):53-54. 被引量:8
  • 4周应芳,吴北生,李辉,郑淑蓉.CA_(125)测定对子宫肌腺病的诊断价值[J].中华妇产科杂志,1996,31(10):590-593. 被引量:72
  • 5[1]Guerriero S,Ajoss A,Paoleffi Am,et al.Tumor markers and transvaginal ultrasonography in the diagnosis of endometrima[J].Obstet Gynecol,1996,88(3):403-407.
  • 6[3]Kobayashi H,Ida W,Terao T,et al,Molecular characteristics of the CA125antigen produced by human ondometrial epithelial cells:comparson between entopic and heterotopic epithelium[J].Am J Obstet Oynecol.1993,169(2):725.
  • 7[5]June Rosal.阿克曼外科病理学[M].8版.沈阳:辽宁教育出版社,2001:1401.
  • 8[7]Arnold LL,Ascher SM,Schrueter JJ,et al.The nonsurgical diagnosis of adenomyosis[J].Obstetrices Oynecology,1995,86(1):461.
  • 9Patsner B,Mann WJ,Cohen H,et al.Predictive value of preoperative serum CA125 levels in clinically localized and advanced endometrial carcinoma.Am J Obstet Gynecol,1988,158:399-402.
  • 101.4统计学处理采用t检验和χ2检验。 2结果 2.1患者血清肿瘤标志物水平见表1。28例卵巢癌患者血清CA125、CA19.9和CA72.4的水平显著高于46例卵巢良性病变者。虽然卵巢癌组CEA均值较良性病变组高,但差异无显著性(P>0.05)。良性肿瘤者GM-CSF值高于恶性肿瘤者,但差异无显著性(P>0.05)。 表1良性与恶性卵巢病变患者血中各标志物的水平(±s)

共引文献26

同被引文献21

  • 1Bender DP,Sorosky JI,Buller RE,et al.Serum CA125 isan independent prognostic factor in cervical adenocarcino-ma[J].Obstet Gynecol,2003,189(1):113-117.
  • 2TsaiCC,Liu YS,Huang EY,et al.Value of preoperativeserum CA125 in early-stage adenocarcinoma of the uter-ine cervix without pelvic lymph node metastasis[J].Gy-necol Oncol,2006,100(3):591-595.
  • 3Gadducci A,Cosio S,Carpi A,et al.Serum tumor markers in the man agement of ovarian endometrial and cervi-cal cancer[J].Biomed Pharmacother,2004,58(1):24-38.
  • 4Baalbergen A,Ewing-Graham PC,Hop WC,et al.Prog-nostic factors in adenocarcinoma of the uterine cervix[J].Gynecol Oncol,2004,92(1):262-267.
  • 5Sardi J,Sananes C,Giaroli A,et al.Result s of a prospec-tive randomized trial with neoadjuvant chemotherapy instageⅠB,bulky,squamous carcinoma of the cervix[J].Gynecol Oncol,1993,49(2):156-165.
  • 6Duk JM,Aalders JG,Fleuren GJ.Tumor markers CA 125,squamous cell carcinoma antigen,and carcinoembryonicantigen in patients with adenocarcinoma of the uterinecervix[J].Obstet Gynecol,1989,73(4):661-668.
  • 7Natsume N,Aoki Y,Kase H,et al.Ovarian metastasis instageⅠb andⅡcervical adenocarcinoma[J].GynecolOncol,1999,74(2):255-258.
  • 8Chung HH,Kim JW,Park NH,et al.Use of preoperativeserum CA-125 levels for prediction of lymph node metas-tasis and prognosis in endometrial cancer[J].Acta Ob-stet Gynecol Scand,2006,85(12):1501-1505.
  • 9Kotowicz B,Kaminska J,Fuksiewicz M,et al.Clinicalsignificance of serum CA-125 and soluble tumor necro-sis factor receptor type I in cervical adenocarcinoma pa-tients[J].Int J Gynecol Cancer,2010,20(4):588-592.
  • 10尹如铁,潘小玲,高雪梅.盆腔炎性包块与盆腔肿瘤鉴别诊断及临床处理[J].中国实用妇科与产科杂志,2008,24(4):251-253. 被引量:33

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部